Gene · 4926
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial. | Front Immunol | 2023 | 37908361 | PubTator, text mining | PubMed |
| Decoding Hidden Messengers: Proteomic Profiling of Exosomes in Mammary Cancer Research. | Biomedicines | 2023 | 37893211 | PubTator, text mining | PubMed |
| Diverse microtubule-targeted anticancer agents kill cells by inducing chromosome missegregation on multipolar spindles. | PLoS Biol | 2023 | 37883329 | PubTator, text mining | PubMed |
| New-onset Immune-mediated Necrotizing Myopathy and Trigeminal Neuropathy after SARS-CoV-2 mRNA Vaccination in a Patient with Rheumatoid Arthritis and Sjögren's Syndrome. | Intern Med | 2023 | 37839879 | PubTator, text mining | PubMed |
| Overview, Diagnosis, and Perioperative Systemic Therapy of Upper Tract Urothelial Carcinoma. | Cancers (Basel) | 2023 | 37835507 | PubTator, text mining | PubMed |
| Proteomics Profiling of Bladder Cancer Tissues from Early to Advanced Stages Reveals NNMT and GALK1 as Biomarkers for Early Detection and Prognosis of BCa. | Int J Mol Sci | 2023 | 37834386 | PubTator, text mining | PubMed |
| Estrogens, Estrogen Receptors and Tumor Microenvironment in Ovarian Cancer. | Int J Mol Sci | 2023 | 37834120 | PubTator, text mining | PubMed |
| ADP-ribosylation from molecular mechanisms to therapeutic implications. | Cell | 2023 | 37832523 | PubTator, text mining | PubMed |
| Growing and dividing: how O-GlcNAcylation leads the way. | J Biol Chem | 2023 | 37820866 | PubTator, text mining | PubMed |
| Advances in chemoablation in upper tract urothelial carcinoma: overview of indications and treatment patterns. | Transl Androl Urol | 2023 | 37814691 | PubTator, text mining | PubMed |
| Construction of 3D and 2D contrast-enhanced CT radiomics for prediction of CGB3 expression level and clinical prognosis in bladder cancer. | Heliyon | 2023 | 37809854 | PubTator, text mining | PubMed |
| Exosome, the glass slipper for Cinderella of cancer-bladder cancer? | J Nanobiotechnology | 2023 | 37805491 | PubTator, text mining | PubMed |
| The Evolution of Polyclonal Antibody from Specific Epitope 47kDA for Detection of Bladder Cancer. | Asian Pac J Cancer Prev | 2023 | 37774067 | PubTator, text mining | PubMed |
| Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers. | Int J Mol Sci | 2023 | 37762677 | PubTator, text mining | PubMed |
| Molybdenum Disulfide as Tunable Electrochemical and Optical Biosensing Platforms for Cancer Biomarker Detection: A Review. | Biosensors (Basel) | 2023 | 37754082 | PubTator, text mining | PubMed |
| Lateral Flow Assay: A Summary of Recent Progress for Improving Assay Performance. | Biosensors (Basel) | 2023 | 37754072 | PubTator, text mining | PubMed |
| Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors. | Front Genet | 2023 | 37745860 | PubTator, text mining | PubMed |
| A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients. | BMC Med | 2023 | 37726806 | PubTator, text mining | PubMed |
| Combined prediction and design reveals the target recognition mechanism of an intrinsically disordered protein interaction domain. | Proc Natl Acad Sci U S A | 2023 | 37722056 | PubTator, text mining | PubMed |
| Novel potential urinary biomarkers for effective diagnosis and prognostic evaluation of high-grade bladder cancer. | Transl Cancer Res | 2023 | 37701108 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4926/papers?page=8